Literature DB >> 19428091

Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia and BPH treatment.

Wayne J G Hellstrom1, François Giuliano, Raymond C Rosen.   

Abstract

Although knowledge of the neurophysiology and neuropharmacology of ejaculation has increased in the last decade, our understanding of the pathophysiology of the different types of ejaculatory dysfunction (EjD) remains limited. Epidemiological studies provide strong evidence of a relationship between lower urinary tract symptoms (LUTS) and EjD in aging men. Clinical trial results indicate that treatments for LUTS suggestive of benign prostatic hyperplasia (BPH) can be associated with EjD side effects. The present article provides an overview of current knowledge on the physiology of ejaculation, possible common pathophysiologic mechanisms for EjD and LUTS, with a focus on LUTS/BPH, and the effects of different BPH treatments on ejaculation.

Entities:  

Mesh:

Year:  2009        PMID: 19428091     DOI: 10.1016/j.urology.2008.06.048

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

Review 1.  The Effect of LUTS/BPH and Treatments on Ejaculatory Function.

Authors:  Michelle Herberts; Michael Butcher; Tobias Köhler
Journal:  Curr Urol Rep       Date:  2016-07       Impact factor: 3.092

2.  Risk factors of sexual dysfunction after transurethral resection of the prostate (TURP): a 12 months follow-up.

Authors:  V Favilla; S Cimino; C Salamone; E Fragalà; M Madonia; R Condorelli; S La Vignera; L Mongioì; F Pirozzi Farina; G I Russo; G Morgia
Journal:  J Endocrinol Invest       Date:  2013-12       Impact factor: 4.256

3.  Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH.

Authors:  Nadir I Osman; Christopher R Chapple; Teuvo L Tammela; Andreas Eisenhardt; Matthias Oelke
Journal:  World J Urol       Date:  2015-02-25       Impact factor: 4.226

4.  Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).

Authors:  Kuo-Pao Lai; Chiung-Kuei Huang; Lei-Ya Fang; Kouji Izumi; Chi-Wen Lo; Ronald Wood; Jon Kindblom; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2013-07-26

5.  A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice.

Authors:  M P J Nicolai; S S Liem; S Both; R C M Pelger; H Putter; M J Schalij; H W Elzevier
Journal:  Neth Heart J       Date:  2014-01       Impact factor: 2.380

6.  Ejaculatory Dysfunction in Patients Presenting to a Men's Health Clinic: A Retrospective Cohort Study.

Authors:  Alex M Kasman; Hriday P Bhambhvani; Michael L Eisenberg
Journal:  Sex Med       Date:  2020-06-15       Impact factor: 2.491

7.  Significant relationship between parameters measured by transrectal color Doppler ultrasound and sexual dysfunction in patients with BPH 12 months after TURP.

Authors:  Li K Chen; Yu W Lai; Li P Chiu; Saint Shiou-Sheng Chen
Journal:  BMC Urol       Date:  2021-01-13       Impact factor: 2.264

8.  Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS).

Authors:  Tyler Greer; Ling Hao; Anatoliy Nechyporenko; Sanghee Lee; Chad M Vezina; Will A Ricke; Paul C Marker; Dale E Bjorling; Wade Bushman; Lingjun Li
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

Review 9.  Ejaculatory dysfunction in the treatment of lower urinary tract symptoms.

Authors:  Kenneth Jackson DeLay; Max Nutt; Kevin T McVary
Journal:  Transl Androl Urol       Date:  2016-08

Review 10.  Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review.

Authors:  Nicolas Couteau; Igor Duquesne; Panthier Frédéric; Nicolas Thiounn; Marc-Olivier Timsit; Arnaud Mejean; Ugo Pinar; François Audenet
Journal:  J Clin Med       Date:  2021-12-10       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.